MXI1 and central nervous system cancer: Results are reported in Figure 2B,C and confirm the significant decrease of the proliferation rate of glioma cells overexpressing MXI1. The number of U87/MXI1sense cells 4 days after plating was 30% that of untransfected cells and 35% that of U87/MXI1antisense cells (P<0.05).